Augusta University
Augusta University alumnus Dr. William S. Hagler, the Department of Psychiatry and the James and Jean Culver Vision Discovery Institute at the Medical College of Georgia are sponsoring a conference Oct. 11 in the Jaguar Student Activities Center.
Augusta University experts ready to talk trending news topics, including the myth of "curing" cancer.
It's a progressive eye disease that's plagued NBA superstar Steph Curry. Now scientists at MCG have a $2.1 million grant to learn more about keatoconus' causes and identify points to better diagnose, treat and maybe even prevent it.
MCG investigators working on associating a protein profile in the eye's fluid with obvious structural damage to the eye glaucoma causes. They think that may lead to early detection and new treatment targets for the leading cause of blindness...
Dr. Julian J. Nussbaum will resign his duties as chief executive officer for Augusta University Medical Associates.
When a car crash or explosion results in an optic nerve injury, eliminating an enzyme known to promote inflammation appears to aid recovery, scientists report.
Scientists at the Medical College of Georgia are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension.
In her four years at Augusta University, honors student Shubhra Rajpurohit has accomplished a lot. More importantly, though, she’s discovered her passion: research.
Enzyme arginase 1, known to help our liver get rid of ammonia, can also help repair and protect our retina.
Augusta University and Windsor Jewelers join forces to further research in vision care.
Dr. Kathryn Bollinger, ophthalmologist, glaucoma specialist and retinal cell biologist, is working on protections from glaucoma.
The third annual Eye Ball, a fundraiser for the James and Jean Culver Vision Discovery Institute at Augusta University, will be held at 6 p.m. Feb. 24 at the Ritz-Carlton at Reynolds Plantation in Greensboro, Georgia.
Scientists have shown that a medicine prescribed for severe pain can help preserve vision in a model of severe, blinding retinal degeneration. Now they want to know more about how it works.
Dr. Sylvia Smith, co-director of the James and Jean Culver Vision Discovery Institute, was awarded a $300,000 grant to further study retinitis pigmentosa.
